ZA200208372B - Oxidation process for preparing the intermediate 6.Alpha.,9.Alpha.-Difluoro-11.Beta., 17.Alpha.-Dihydroxy-16.Alpha.-Methyl-Androst-1,4-Dien-3-One 17.Beta.-Carboxylic acid. - Google Patents
Oxidation process for preparing the intermediate 6.Alpha.,9.Alpha.-Difluoro-11.Beta., 17.Alpha.-Dihydroxy-16.Alpha.-Methyl-Androst-1,4-Dien-3-One 17.Beta.-Carboxylic acid. Download PDFInfo
- Publication number
- ZA200208372B ZA200208372B ZA200208372A ZA200208372A ZA200208372B ZA 200208372 B ZA200208372 B ZA 200208372B ZA 200208372 A ZA200208372 A ZA 200208372A ZA 200208372 A ZA200208372 A ZA 200208372A ZA 200208372 B ZA200208372 B ZA 200208372B
- Authority
- ZA
- South Africa
- Prior art keywords
- alpha
- process according
- formula
- compound
- water
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J3/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by one carbon atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J31/00—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Steroid Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0017988.7A GB0017988D0 (en) | 2000-07-21 | 2000-07-21 | Novel process |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ZA200208372B true ZA200208372B (en) | 2004-02-11 |
Family
ID=9896132
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ZA200208372A ZA200208372B (en) | 2000-07-21 | 2002-10-17 | Oxidation process for preparing the intermediate 6.Alpha.,9.Alpha.-Difluoro-11.Beta., 17.Alpha.-Dihydroxy-16.Alpha.-Methyl-Androst-1,4-Dien-3-One 17.Beta.-Carboxylic acid. |
Country Status (26)
| Country | Link |
|---|---|
| US (1) | US20040043974A1 (enExample) |
| EP (1) | EP1301526B1 (enExample) |
| JP (1) | JP2004504403A (enExample) |
| KR (1) | KR100787293B1 (enExample) |
| CN (1) | CN1315864C (enExample) |
| AT (1) | ATE398628T1 (enExample) |
| AU (2) | AU7090601A (enExample) |
| BR (1) | BR0110430A (enExample) |
| CA (1) | CA2406963A1 (enExample) |
| CY (1) | CY1108553T1 (enExample) |
| CZ (1) | CZ302592B6 (enExample) |
| DE (1) | DE60134472D1 (enExample) |
| DK (1) | DK1301526T3 (enExample) |
| ES (1) | ES2307628T3 (enExample) |
| GB (1) | GB0017988D0 (enExample) |
| HK (1) | HK1056179B (enExample) |
| HU (1) | HUP0301108A3 (enExample) |
| IL (2) | IL152348A0 (enExample) |
| MX (1) | MXPA02010967A (enExample) |
| NO (1) | NO324836B1 (enExample) |
| NZ (1) | NZ522083A (enExample) |
| PL (1) | PL206652B1 (enExample) |
| PT (1) | PT1301526E (enExample) |
| SI (1) | SI1301526T1 (enExample) |
| WO (1) | WO2002008243A1 (enExample) |
| ZA (1) | ZA200208372B (enExample) |
Families Citing this family (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6858593B2 (en) | 2000-08-05 | 2005-02-22 | Smithkline Beecham Corporation | Anti-inflammatory androstane derivative compositions |
| US6777399B2 (en) | 2000-08-05 | 2004-08-17 | Smithkline Beecham Corporation | Anti-inflammatory androstane derivative compositions |
| US6858596B2 (en) | 2000-08-05 | 2005-02-22 | Smithkline Beecham Corporation | Formulation containing anti-inflammatory androstane derivative |
| US6787532B2 (en) | 2000-08-05 | 2004-09-07 | Smithkline Beecham Corporation | Formulation containing anti-inflammatory androstane derivatives |
| AU7649701A (en) | 2000-08-05 | 2002-02-18 | Glaxo Group Ltd | 17.beta.-carbothioate 17.alpha.-arylcarbonyloxyloxy androstane derivative as anti-inflammatory agents |
| US6777400B2 (en) | 2000-08-05 | 2004-08-17 | Smithkline Beecham Corporation | Anti-inflammatory androstane derivative compositions |
| US6759398B2 (en) | 2000-08-05 | 2004-07-06 | Smithkline Beecham Corporation | Anti-inflammatory androstane derivative |
| US6750210B2 (en) | 2000-08-05 | 2004-06-15 | Smithkline Beecham Corporation | Formulation containing novel anti-inflammatory androstane derivative |
| GB0019172D0 (en) | 2000-08-05 | 2000-09-27 | Glaxo Group Ltd | Novel compounds |
| UA77656C2 (en) | 2001-04-07 | 2007-01-15 | Glaxo Group Ltd | S-fluoromethyl ester of 6-alpha, 9-alpha-difluoro-17-alpha-[(2-furanylcarbonyl)oxy]-11-beta-hydroxy-16- alpha-methyl-3-oxoandrosta-1,4-dien-17-beta-carbothioacid as anti-inflammatory agent |
| CN1302007C (zh) | 2001-04-30 | 2007-02-28 | 葛兰素集团有限公司 | 具有抗炎性的在17.α位上具有环酯基的雄甾烷的17.β.－硫代羧酸酯衍生物 |
| GB2389530B (en) | 2002-06-14 | 2007-01-10 | Cipla Ltd | Pharmaceutical compositions |
| IL150654A (en) | 2002-07-09 | 2006-12-10 | Ori Lerman | Method for acid isolation 6α, 9α - difluoro - ß, 17α11 - dihydroxy - 16α - methylfargana - 3 - oxo - 1, 4 - diene - 17ß - carboxylate |
| EP1611149A1 (en) * | 2003-04-04 | 2006-01-04 | Alpharma APS | Process for the preparation of steroidal carbothioic acid derivatives and intermediates |
| EP1466920A1 (en) * | 2003-04-04 | 2004-10-13 | Alpharma APS | Process for the preparation of steroidal 17 beta-carbothioates |
| EP1526139A1 (en) * | 2003-10-24 | 2005-04-27 | S.N.I.F.F. Italia S.P.A. | A process for preparing highly pure androstane 17-beta-carboxylic acids and androstane 17-beta-carbothioic acid fluoromethyl esters |
| GB0612027D0 (en) | 2006-06-16 | 2006-07-26 | Glaxo Group Ltd | Novel process |
| NO331891B1 (no) * | 2007-03-20 | 2012-04-30 | Clavis Pharma Asa | Kjemiske forbindelser, et farmasoytisk preparat inneholdende slike forbindelser, samt anvendelse derav for behandling av kreft, inflammasjon og KOLS |
| PT105139B (pt) * | 2010-06-01 | 2013-01-29 | Hovione Farmaciencia S A | Método para a monofluorometilação de substratos orgânicos para preparação de compostos orgânicos biologicamente activos |
| EP2611821A2 (en) | 2010-09-01 | 2013-07-10 | Cadila Healthcare Limited | Process for preparing fluticasone propionate/furoate |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3636010A (en) * | 1968-12-23 | 1972-01-18 | Ciba Geigy Corp | Esters of steroid-17-carboxylic acids |
| US4198336A (en) * | 1978-04-05 | 1980-04-15 | Syntex (U.S.A.) Inc. | Chemical process for preparing androsta-4-ene 17α-carboxylic acids |
| US4188385A (en) * | 1978-04-05 | 1980-02-12 | Syntex (U.S.A.) Inc. | Thioetianic acid derivatives |
| US4263289A (en) * | 1978-04-05 | 1981-04-21 | Syntex (U.S.A.) Inc. | Thio etianic acid derivatives |
| NL187577C (nl) * | 1978-04-05 | 1991-11-18 | Sibla Srl | 3-acetoxy-9beta,11beta-epoxy-pregna-1,3,5-trienen, werkwijze voor de bereiding daarvan en werkwijze voor de bereiding van 6alfa-halogeen-pregna-1,4-dieen-3-onen. |
| CY1291A (en) * | 1980-02-15 | 1985-10-18 | Glaxo Group Ltd | Androstane 17 beta carbothioates |
| US5646136A (en) * | 1994-01-04 | 1997-07-08 | Duke University | Methods of inhibiting angiogenesis and tumor growth, and treating ophthalmologic conditions with angiostatic and therapeutic steroids |
| SK89198A3 (en) * | 1995-12-29 | 1999-03-12 | Glaxo Group Ltd | Lactone derivatives of 17.beta.-carboxy, carbothio and amide androstane derivatives |
| US20020133032A1 (en) * | 2000-02-25 | 2002-09-19 | Jufang Barkalow | Method for the preparation of fluticasone and related 17beta-carbothioic esters using a novel carbothioic acid synthesis and novel purification methods |
| ATE328744T1 (de) * | 2000-04-04 | 2006-06-15 | Celanese Int Corp | Tintenaufnehmende zusammensetzung, die polyvinylalkohol mit gepfropften amingruppen enthaelt |
| US6777400B2 (en) * | 2000-08-05 | 2004-08-17 | Smithkline Beecham Corporation | Anti-inflammatory androstane derivative compositions |
-
2000
- 2000-07-21 GB GBGB0017988.7A patent/GB0017988D0/en not_active Ceased
-
2001
- 2001-07-20 CA CA002406963A patent/CA2406963A1/en not_active Abandoned
- 2001-07-20 HU HU0301108A patent/HUP0301108A3/hu unknown
- 2001-07-20 ES ES01949791T patent/ES2307628T3/es not_active Expired - Lifetime
- 2001-07-20 AU AU7090601A patent/AU7090601A/xx active Pending
- 2001-07-20 MX MXPA02010967A patent/MXPA02010967A/es active IP Right Grant
- 2001-07-20 DK DK01949791T patent/DK1301526T3/da active
- 2001-07-20 PL PL359462A patent/PL206652B1/pl not_active IP Right Cessation
- 2001-07-20 JP JP2002514148A patent/JP2004504403A/ja active Pending
- 2001-07-20 AT AT01949791T patent/ATE398628T1/de active
- 2001-07-20 AU AU2001270906A patent/AU2001270906B2/en not_active Ceased
- 2001-07-20 DE DE60134472T patent/DE60134472D1/de not_active Expired - Lifetime
- 2001-07-20 WO PCT/GB2001/003289 patent/WO2002008243A1/en not_active Ceased
- 2001-07-20 HK HK03106680.9A patent/HK1056179B/en not_active IP Right Cessation
- 2001-07-20 NZ NZ522083A patent/NZ522083A/en not_active IP Right Cessation
- 2001-07-20 CN CNB018114407A patent/CN1315864C/zh not_active Expired - Fee Related
- 2001-07-20 PT PT01949791T patent/PT1301526E/pt unknown
- 2001-07-20 EP EP01949791A patent/EP1301526B1/en not_active Expired - Lifetime
- 2001-07-20 BR BR0110430-6A patent/BR0110430A/pt not_active Application Discontinuation
- 2001-07-20 IL IL15234801A patent/IL152348A0/xx active IP Right Grant
- 2001-07-20 US US10/333,537 patent/US20040043974A1/en not_active Abandoned
- 2001-07-20 CZ CZ20023472A patent/CZ302592B6/cs not_active IP Right Cessation
- 2001-07-20 SI SI200130851T patent/SI1301526T1/sl unknown
- 2001-07-20 KR KR1020027014367A patent/KR100787293B1/ko not_active Expired - Fee Related
-
2002
- 2002-10-17 IL IL152348A patent/IL152348A/en not_active IP Right Cessation
- 2002-10-17 ZA ZA200208372A patent/ZA200208372B/en unknown
- 2002-10-21 NO NO20025054A patent/NO324836B1/no not_active IP Right Cessation
-
2008
- 2008-09-03 CY CY20081100942T patent/CY1108553T1/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP1301526B1 (en) | Oxidation process for preparing the intermediate 6.alpha.,9.alpha.-difluoro-11.beta.,17.alpha.-dihydroxy-16.alpha.-methyl-androst-1,4-dien-3-one 17.beta.-carboxylic acid | |
| AU2001270906A1 (en) | Oxidation process for preparing the intermediate 6.alpha.,9.alpha.-difluoro-11.beta.,17.alpha.-dihydroxy-16.a lpha.-methyl-androst-1,4-dien-3-one 17.beta.-carboxylic acid | |
| US20080125407A1 (en) | Method for preparation of fluticasone propionate | |
| KR20090078329A (ko) | 시클레소니드의 제조방법 및 그의 결정형 | |
| CA2709971A1 (en) | Solid and crystalline dutasteride and processes for preparation thereof | |
| US8148353B2 (en) | Polymorphs of fluticasone furoate and process for preparation thereof | |
| JP3746174B2 (ja) | モメタゾンフロエートの製造方法 | |
| WO2012079275A1 (zh) | 氟替卡松糠酸酯的制备方法 | |
| US20050090675A1 (en) | Process for preparing highly pure androstane 17-beta-carboxylic acids and 17-beta-carbothioic acid fluoromethyl esters thereof | |
| CA2584052C (en) | Process for the esterification of a carbothioic acid | |
| JP2001261696A (ja) | ウルソデオキシコール酸の第三級アミン塩及びこれを利用したウルソデオキシコール酸の製造方法 | |
| CA2473753A1 (en) | Process for the production of 6.alpha.,9.alpha-difluoro-17.alpha.-(1-oxopropoxy-11.beta.-hydroxy-16.alpha.-methyl-3-oxo-androst-1,4-diene-17.beta.-carbothioic acid | |
| JP4076097B2 (ja) | （１１β，１６β）―２１―（３―カルボキシ―３―オキソプロポキシ）―１１―ヒドロキシ―２’―メチル―５’Ｈ―プレグナ―１，４―ジエノ［１７，１６―Ｄ］オキサゾール―３，２０―ジオンの製造 | |
| JP2980992B2 (ja) | ６−ハロゲノ−２−オキサプレグナ−４，６−ジエン−３−オン化合物の製造方法 | |
| JPH01197487A (ja) | ５−オキソミルベマイシン誘導体の製造方法 | |
| JP2003246790A (ja) | プレグナン誘導体の製造方法 | |
| KR20030015498A (ko) | 메틸 3,7-디프로폭시 콜레이트의 제조방법 |